Ziprasidone Intramuscular Injection 20 mg/mL Suppliers & Bulk Manufacturers

Available Forms: Intramuscular Injection (IM)

Available Strengths: 20 mg/mL

Reference Brands: Zeldox®(EU); Geodon®(US)

Category: Antipsychotropic Drugs

Ziprasidone is an atypical antipsychotic that antagonizes dopamine D2 and serotonin 5-HT2A receptors, helping to rapidly reduce acute psychotic symptoms and agitation. The intramuscular (IM) formulation is used for the short-term treatment of acute agitation in patients with schizophrenia. It provides fast onset of action, making it ideal for emergency settings when rapid behavioral control is needed.

Product Description: Ziprasidone intramuscular injection (brand name: Geodon) is FDA-approved in the United States for the acute treatment of agitation in patients with schizophrenia. It is intended for short-term use when rapid control of symptoms is clinically necessary. In the European Union, it is approved under the name Zeldox for similar indications. Regulatory approval requires GMP-compliant injectable manufacturing, validated safety and efficacy data, and pharmacokinetic studies supporting rapid onset. U.S. labeling includes warnings for QT interval prolongation and cardiac risk. EU approvals require Risk Management Plans (RMPs) and ongoing pharmacovigilance. For sourcing and dossier-ready options, visit Pharmatradz.com.